AKTS insider buying and SEC filings, explained
Aktis Oncology, Inc. · CIK 2035832
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$114.3M
Insiders who bought
6
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$259K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 23, 2026 | Planned (10b5-1) | Akos Czibere (Chief Medical Officer) sold 12,500 shares at about $20.69 ($259K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 24, 2026 |
| Jan 12, 2026 | Purchase (code P) | Todd Foley (Director and 10% owner) bought 232,870 shares indirectly at $18.00 ($4.2M), reported as a purchase (code P). Indirect holdings up 6% to 4,235,403 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 14, 2026 |
| Jan 12, 2026 | Purchase (code P) | Luke Evnin (10% owner) bought 1,112,777 shares indirectly at $18.00 ($20.0M), reported as a purchase (code P). Indirect holdings up 12% to 10,260,064 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners. | SEC filing Filed Jan 14, 2026 |
| Jan 12, 2026 | Purchase (code P) | Ansbert Gadicke (10% owner) bought 1,112,777 shares indirectly at $18.00 ($20.0M), reported as a purchase (code P). Indirect holdings up 12% to 10,260,064 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Jan 14, 2026 |
| Jan 12, 2026 | Purchase (code P) | Vida Ventures II, LLC (10% owner) bought 835,000 shares indirectly at $18.00 ($15.0M), reported as a purchase (code P). New position of 157,387 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 12, 2026 |
| Jan 12, 2026 | Purchase (code P) | Helen Susan Kim (Director and 10% owner) bought 835,000 shares indirectly at $18.00 ($15.0M), reported as a purchase (code P). New position of 157,387 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 12, 2026 |
| Jan 12, 2026 | Purchase (code P) | Oleg Nodelman (Director) bought 2,222,222 shares indirectly at $18.00 ($40.0M), reported as a purchase (code P). New position of 347,305 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 12, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
6 insiders bought in 30 days
$114.3M in purchases since Jan 12, 2026 · Purchases traded Jan 12, 2026 to Jan 12, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Oleg Nodelman (Director) | $40.0M | Jan 12, 2026 | SEC filing |
| Helen Susan Kim (Director) | $15.0M | Jan 12, 2026 | SEC filing |
| Vida Ventures II, LLC (10% owner) | $15.0M | Jan 12, 2026 | SEC filing |
| Ansbert Gadicke (10% owner) | $20.0M | Jan 12, 2026 | SEC filing |
| Luke Evnin (10% owner) | $20.0M | Jan 12, 2026 | SEC filing |
| Todd Foley (Director) | $4.2M | Jan 12, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AKTS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.